NCT04902911View on ClinicalTrials.gov

Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold)

TerminatedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

August 17, 2022

Study Completion Date

August 17, 2022

Conditions
Covid19
Interventions
DEVICE

COVID-19 SARS-CoV IgG/IgM antibody rapid test

Needle stick point of care and 3mL vial of blood will be collected and tested for individual without history of COVID-19 and immunization as well as a second group composed of individuals with history of COVID-19

Trial Locations (1)

53226

Froedtert Health WAC, Wauwatosa

Sponsors

Collaborators (1)

Novir
All Listed Sponsors
collaborator

Novir

UNKNOWN

lead

Medical College of Wisconsin

OTHER